UPPTHERA

Private

IncheonHealthcare & Life Scienceshttps://www.uppthera.com/

Last Round

Series B

Extension

Jul 24, 2023

Total Funding Raised

$41.1M

Company Overview

UPPTHERA is a pharmaceutical company that develops innovative drugs based on targeted protein degradation technology to address unmet medical needs in oncology and other disease areas.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

targeted protein degradationTPDPROTACdrug discovery platformE3 ligasechemoproteomicsundruggable targetsprotein degraderbiotech R&Dligand screeningprecision medicinebioinformaticstherapeutic candidatesdrug developmentdegrader discovery

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

UPPTHERA Comps

Public and private peers based on sector, stage, and business model.

UPPTHERA comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

UPPTHERA Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series B Extension	Jul 24, 2023
Series B	May 18, 2022
Series A	Jul 14, 2020
Pre Seed	Mar 1, 2019

View all Funding Rounds

Key People

Founding team and executive leadership

Sanha Son

Co-founder Chief Business Officer

Founding Team

Heung Sik Hahm

Chemistry CTO

Executive Team

SooHee Ryu

Chief Technology Officer

Executive Team

Hyun Seung Shim

CFO 경영관리그룹 그룹장

Executive Team

View all key people

UPPTHERA Investors

Notable investors and investment history

UPPTHERA investors
Investor	Rounds
KDB Capital Corp	Series B, Series A
Paratus Investment	Series B
Meritz Securities Co., Ltd.	Series B
SBI Investment Korea	Series B
Enlight Ventures	Series B, Series A
IMM Investment	Series B, Series A
SBI Investment Co., Ltd.	Series B, Series A

View all Investors

UPPTHERA Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

UPPTHERA Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about UPPTHERA's valuation, stock price, and market status.

Firmographic Details

HeadquartersIncheon

Employee Range20

Year Founded2018

Last FundingJul 24, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.